News
With Proper Training, AI Can Be a Useful Tool in Epilepsy Management
- Author:
- Frieda Wiley, PharmD
“Artificial intelligence will not replace clinicians, but clinicians assisted by artificial intelligence will replace clinicians without...
News
Genetic Testing Is Recommended for Adult Patients With Epilepsy
- Author:
- Frieda Wiley, PharmD
Genetic testing provides a more comprehensive overview of a patient’s genetic landscape, and it can enhance the...
News
Alzheimer’s and Epilepsy: Can Shared Molecular Mechanisms Reveal New Opportunities for Epilepsy?
- Author:
- Frieda Wiley, PharmD
The prognosis looks comparatively worse for patients who have Alzheimer’s disease and comorbid epilepsy than for patients who have only epilepsy...
News
Despite Few CNS Gene Therapies for Epilepsy, New Research Offers Hope
- Author:
- Frieda Wiley, PharmD
Ongoing research is focused on new gene therapies that might one day become effective options in treating...
News

Emerging therapies in Duchenne and facioscapulohumeral muscular dystrophy
- Author:
- Frieda Wiley, PharmD
Newly approved and investigational therapies, and enhanced diagnostics, are sparking optimism about treating MD especially Duchenne and...
News

Mediterranean diet improves cognition in MS
- Author:
- Frieda Wiley, PharmD
Dietary modification showed stronger associations between diet and cognition with progressive disease as opposed to relapsing disease.
News
MS bears no effect on certain pregnancy complications, stillbirth, or congenital deformation
- Author:
- Frieda Wiley, PharmD
Women with MS were more likely to have elective C-sections, induced labor, and babies with low birth weight based on their gestational age.
News

EULAR recommendations define strategies to improve adherence in RMDs
- Author:
- Frieda Wiley, PharmD
A task force put together four overarching principles and nine points to consider to address adherence to both pharmacologic and nonpharmacologic...
News
Are patients with epilepsy at increased risk of COVID-19 infection?
- Author:
- Frieda Wiley, PharmD
The COVID risk may not be elevated, but vigilance and caution are still warranted.